{"id":"W4416410316","doi":"10.1016/j.annonc.2025.11.005","title":"Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Alberta","funders":"Seagen; Gilead Sciences; Roche; Novartis; Daiichi-Sankyo; Pfizer; Bristol-Myers Squibb","keywords":"Metastatic breast cancer; Trastuzumab emtansine; Trastuzumab; Phases of clinical research; Randomized controlled trial; Clinical endpoint","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002157794,0.001406831,0.002528535,0.0003526579,0.0003443639,0.001401144,0.0008183749,0.001151614,0.005853633],"category_scores_gemma":[0.001569606,0.0006423824,0.002099776,0.0004808916,0.0008525769,0.001417218,0.0004598835,0.003424745,0.0008786392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001273715,"about_ca_system_score_gemma":0.001410184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001620702,"about_ca_topic_score_gemma":0.006771389,"domain_scores_codex":[0.9991841,0.0004653881,0.00003097743,0.0001213397,0.00004789165,0.000150373],"domain_scores_gemma":[0.9992762,0.0001760897,0.000163418,0.00005958056,0.00003223843,0.0002923569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9604715,0.004294488,0.002333829,0.0003461717,0.001934801,0.00003926208,0.00005394125,0.001113836,0.002055117,0.0001518207,0.00220704,0.02499828],"study_design_scores_gemma":[0.926369,0.05958117,0.00841081,0.00004558549,0.001527709,0.0001044307,0.00005857302,0.001126511,0.0006127051,0.0003305198,0.001809871,0.00002318125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986453,0.006127174,0.0004397339,0.001096965,0.0004075133,0.00092948,0.001520202,0.0001134232,0.002912532],"genre_scores_gemma":[0.9904799,0.002347118,0.0005180908,0.0008387119,0.0002718259,0.000705712,0.002055069,0.00003246145,0.002751082],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005853633,"threshold_uncertainty_score":0.01958233,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03351120848827747,"score_gpt":0.4264416677257516,"score_spread":0.3929304592374741,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}